000			02302 a2200661 4500
005			20250516092947.0
264		0	_c20121016
008			201210s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2012.05.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aNout, Remi A
245	0	0	_aImproved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation. _h[electronic resource]
260			_bGynecologic oncology _cSep 2012
300			_a466-73 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdaptor Proteins, Signal Transducing _xgenetics
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aDisease-Free Survival
650	0	4	_aEndometrial Neoplasms _xgenetics
650	0	4	_aExons
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMethylation
650	0	4	_aMicrosatellite Instability
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aMutL Protein Homolog 1
650	0	4	_aMutation
650	0	4	_aNeoplasm Recurrence, Local _xmetabolism
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aPTEN Phosphohydrolase _xmetabolism
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProportional Hazards Models
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aProto-Oncogene Proteins p21(ras)
650	0	4	_aRisk Assessment
650	0	4	_aSequence Analysis, DNA
650	0	4	_aTranscription Factors _xgenetics
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_aWnt Signaling Pathway _xgenetics
650	0	4	_abeta Catenin _xmetabolism
650	0	4	_aras Proteins _xgenetics
700	1		_aBosse, Tjalling
700	1		_aCreutzberg, Carien L
700	1		_aJürgenliemk-Schulz, Ina M
700	1		_aJobsen, Jan J
700	1		_aLutgens, Ludy C H W
700	1		_avan der Steen-Banasik, Elzbieta M
700	1		_avan Eijk, Ronald
700	1		_aTer Haar, Natalja T
700	1		_aSmit, Vincent T H B M
773	0		_tGynecologic oncology _gvol. 126 _gno. 3 _gp. 466-73
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2012.05.012 _zAvailable from publisher's website
999			_c21794523 _d21794523